Jamil Khurram, Chief Medical Officer of Galectin Therapeutics Inc. ($GALT), sold common shares on the open market eleven times in the last year, totaling $1.06 million. His most recent sale occurred on January 6, 2026. These sales rank 4,774th among 11,678 insiders, below the average of $8.6 million per seller and 6.4 transactions. Khurram made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 16, 2026 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | A | Stock option (right to buy) | 65000 | $0.00 | 65,000.0000 | 63,180,491 | 9999.99% | 0.10% |
| Jan. 16, 2026 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | A | Restricted Stock Unit | 100000 | $0.00 | 100,000.0000 | 63,180,491 | 9999.99% | 0.16% |
| Jan. 2, 2026 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | M | Common Stock | 60000 | $0.00 | 60,000.0000 | 63,180,491 | 9999.99% | 0.09% |
| Jan. 6, 2026 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | S | Common Stock | 21446 | $3.65 | 0.0000 | 63,180,491 | 100.00% | 0.03% |
| Jan. 5, 2026 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | S | Common stock | 25499 | $3.90 | 21,446.0000 | 63,180,491 | 54.32% | 0.04% |
| Jan. 2, 2026 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | S | Common Stock | 13055 | $4.20 | 46,945.0000 | 63,180,491 | 21.76% | 0.02% |
| Jan. 1, 2026 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | M | Restricted Stock Unit | 60000 | $0.00 | 0.0000 | 63,180,491 | 100.00% | 0.09% |
| Dec. 31, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | M | Stock option (right to buy) | 8125 | $0.00 | 40,625.0000 | 63,180,491 | 16.67% | 0.01% |
| Dec. 31, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | S | Common Stock | 8125 | $4.07 | 0.0000 | 63,180,491 | 100.00% | 0.01% |
| Dec. 31, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | M | Common Stock | 8125 | $1.23 | 8,125.0000 | 63,180,491 | 9999.99% | 0.01% |
| Dec. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | S | Common Stock | 4479 | $7.04 | 0.0000 | 63,180,491 | 100.00% | 0.01% |
| Dec. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | M | Common Stock | 6463 | $2.20 | 6,463.0000 | 63,180,491 | 9999.99% | 0.01% |
| Dec. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | S | Common Stock | 6463 | $7.04 | 0.0000 | 63,180,491 | 100.00% | 0.01% |
| Dec. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | M | Common Stock | 8500 | $2.50 | 8,500.0000 | 63,180,491 | 9999.99% | 0.01% |
| Dec. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | S | Common Stock | 8500 | $7.04 | 0.0000 | 63,180,491 | 100.00% | 0.01% |
| Dec. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | M | Stock option (right to buy) | 6463 | $0.00 | 102,037.0000 | 63,180,491 | 5.96% | 0.01% |
| Dec. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | M | Stock option (right to buy) | 8500 | $0.00 | 50,000.0000 | 63,180,491 | 14.53% | 0.01% |
| Nov. 13, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | M | Stock option (right to buy) | 16250 | $0.00 | 48,750.0000 | 63,180,491 | 25.00% | 0.03% |
| Nov. 13, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | M | Common Stock | 41500 | $2.20 | 45,979.0000 | 63,180,491 | 926.55% | 0.07% |
| Nov. 13, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | S | Common Stock | 21867 | $5.47 | 4,479.0000 | 63,180,491 | 83.00% | 0.03% |
| Nov. 13, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | S | Common Stock | 41500 | $5.47 | 4,479.0000 | 63,180,491 | 90.26% | 0.07% |
| Nov. 13, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | M | Common stock | 16250 | $1.23 | 20,729.0000 | 63,180,491 | 362.80% | 0.03% |
| Nov. 13, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | S | Common stock | 16250 | $5.47 | 4,479.0000 | 63,180,491 | 78.39% | 0.03% |
| Nov. 13, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | M | Stock option (right to buy) | 41500 | $0.00 | 108,500.0000 | 63,180,491 | 27.67% | 0.07% |
| Nov. 13, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | M | Stock option (right to buy) | 41500 | $0.00 | 58,500.0000 | 63,180,491 | 41.50% | 0.07% |
| Nov. 13, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | M | Common Stock | 41500 | $2.50 | 45,979.0000 | 63,180,491 | 926.55% | 0.07% |
| Nov. 13, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | S | Common Stock | 41500 | $5.47 | 4,479.0000 | 63,180,491 | 90.26% | 0.07% |
| Jan. 23, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | A | Restricted Stock Unit | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2025 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | A | Stock Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 23, 2024 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | M | Common Stock | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 23, 2024 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | S | Common Stock | 13654 | $0.88 | 26,346.0000 | 0 | 34.14% | 0.00% |
| Dec. 23, 2024 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | M | Restricted Stock Units | 40000 | $0.00 | 0.0000 | 0 | 0.00% | 0.00% |
| Aug. 1, 2024 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | A | Restricted Stock Unit | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2024 | GALECTIN THERAPEUTICS INC | $GALT | Jamil Khurram | Chief Medical Officer | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |